| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
BRIEF REPORT |
Department of Clinical and Experimental Medicine (D.R., G.M., P.S.), Federico II University Medical School, 80131 Naples, Italy; Unit of Pediatric Endocrinology (G.D.F.), Azienda Ospedaliera di Rilievo Nazionale "G. Rummo," 82100 Benevento, Italy; and Department of General Pathology (M.C.), Second University of Naples, 80121 Naples, Italy
Address all correspondence and requests for reprints to: Giuseppe Mossetti, Dipartimento di Medicina Clinica e Sperimentale, Università Federico II, Via S. Pansini, 5-80131 Naples, Italy. E-mail: giumosse{at}unina.it.
Context: Nephrolithiasis affects about 10% of the population in industrialized countries, with calcium salts composing more than 80% of renal stones. A significant percentage of patients with calcium nephrolithiasis and normal parathyroid function show hypophosphatemia and reduced renal phosphate reabsorption (i.e. a renal phosphate leak).
Objectives: The objective of the study was to compare serum levels of fibroblast growth factor 23 (FGF23), a regulator of phosphate homeostasis, in 110 recurrent stone formers with or without renal phosphate leak, six patients affected by X-linked hypophosphatemic rickets, five patients affected by oncogenic osteomalacia, and 60 unrelated healthy controls.
Design: This was a prospective interventional study.
Methods: Renal phosphate leak was identified based on the occurrence of idiopathic hypophosphatemia [serum phosphate concentration < 2.50 mg/dl (<0.80 mmol/liter)] and reduced renal threshold phosphate concentration [<2.2 mg/liter (<0.70 mmol/liter)].
Results: In 22 stone formers with renal phosphate leak, serum FGF23 concentration was significantly higher as compared with 88 stone formers without renal phosphate leak and with controls [83.3 (65.6101.1) vs. 32.1 (26.837.4) and 24.5 (19.829.1) reference units (RU)/ml, respectively]. Stone formers with renal phosphate leak showed lower FGF23, compared with patients with oncogenic osteomalacia and X-linked hypophosphatemic rickets [572.3 (235.9908.7) RU/ml]. Among stone formers and controls, serum FGF23 concentration displayed a strong inverse association with serum phosphate (r = 0.784, P = 0.009) and the rate of tubular phosphate reabsorption (r = 0.791, P = 0.008).
Conclusions: In our study population, renal phosphate leak affected 20% of stone formers and was strongly associated with increased serum FGF23 concentration.
This article has been cited by other articles:
![]() |
A. L. Tencza, S. Ichikawa, A. Dang, D. Kenagy, E. McCarthy, M. J. Econs, and M. A. Levine Hypophosphatemic Rickets with Hypercalciuria due to Mutation in SLC34A3/Type IIc Sodium-Phosphate Cotransporter: Presentation as Hypercalciuria and Nephrolithiasis J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4433 - 4438. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Levine, C. R. Kleeman, and A. J. Felsenfeld The Journey From Vitamin D-Resistant Rickets to the Regulation of Renal Phosphate Transport Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1866 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bergwitz, M. Bastepe, D. Rendina, G. De Filippo, P. Strazzullo, D. Prie, and G. Friedlander NHERF1 Mutations and Responsiveness of Renal Parathyroid Hormone N. Engl. J. Med., December 11, 2008; 359(24): 2615 - 2617. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |